TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ferring Pharmaceuticals A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
195,563
|
169,632
|
135,211 |
| Earnings before taxes |
11,571
|
8,599
|
7,001 |
| Total assets |
78,681
|
65,311
|
63,591 |
| Current assets |
44,085
|
28,981
|
30,486 |
| Current liabilities |
42,375
|
34,401
|
36,185 |
| Equity capital |
25,403
|
16,405
|
9,362 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.3%
|
25.1%
|
14.7% |
| Turnover per employee |
559
|
485
|
386 |
| Profit as a percentage of turnover |
5.9%
|
5.1%
|
5.2% |
| Return on assets (ROA) | |||
| Current ratio |
104.0%
|
84.2%
|
84.3% |
| Return on equity (ROE) |
45.5%
|
52.4%
|
74.8% |
| Change turnover |
26,309
|
34,421
|
-6,186 |
| Change turnover % |
16%
|
25%
|
-4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.